S&P Futures
3,902.00 +4.25 (+0.11%) Dow Futures
31,241.00 +39.00 (+0.12%) Nasdaq Futures
11,838.00 -40.25 (-0.34%) Russell 2000 Futures
1,771.50 -3.40 (-0.19%) Crude Oil
110.35 +0.46 (+0.42%) Gold
1,845.10 +3.90 (+0.21%)
BiondVax Pharmaceuticals Ltd. (BVXV)
After hours:
Chart Events
Performance Outlook
| Previous Close | 1.2900 |
| Open | 1.3000 |
| Bid | 1.2500 x 1400 |
| Ask | 1.3200 x 1000 |
| Day's Range | 1.2543 - 1.3206 |
| 52 Week Range | 1.0000 - 4.1900 |
| Volume | |
| Avg. Volume | 1,205,722 |
| Market Cap | 24.019M |
| Beta (5Y Monthly) | 2.52 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.2960 |
| Earnings Date | May 13, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
BiondVax to Present at H.C. Wainwright Global Investment Conference
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, today announced that it will present in-person at the H.C. Wainwright Global Investment Conference, on May 24, 2022 in Miami, Florida.
- PR Newswire
BiondVax Provides Update at Biomed Israel Conference and Announces Significant Progress in its Nanosized Antibodies Program
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, announced that Dr. Tamar Ben-Yedidia, BiondVax's Chief Scientific Officer, today presented BiondVax's progress, achieving certain milestones, under its nanosized antibodies (NanoAbs) program.
- PR Newswire
BiondVax to Present at this week's Biomed Israel Conference
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, today announced that it will present at the 20th Biomed Israel Conference and Exhibition, to be held May 10-12, 2022, in Tel Aviv, Israel.
